Ephedrine, Caffeine And Aspirin: Safety And Efficacy For Treatment Of Human Obesity
| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | n/a |
| Number of Subjects | 24 |
| Sex | n/a |
Study conducted in 34 morbidly obese persons (BMI average 37) with 75-150mg ephedrine, 150mg caffeine, and 330mg aspirin.
2.2kg was lost over 8 weeks without any dietary restriction versus 0.7kg in placebo.
5 subjects on ECA continued for 5 months without caloric restriction (optional) and lost an additional 5.2kg, the 6th subject imposed caloric restriction and lost 66kg over a period of 13 months.
No adverse effects noted.
